COMMENTARY: Dalteparin reduced venous thromboembolic events without increased bleeding in acutely ill medical patients

Spandorfer, John
March 2005
ACP Journal Club;Mar/Apr2005, Vol. 142 Issue 2, p40
Academic Journal
The article reports that dalteparin reduced venous thromboembolic events without increased bleeding in acutely ill medical patients. 25 percent of all venous thromboembolic events in the general population occur after an acute medical illness. Deep venous thrombosis (DVT) prophylaxis is underutilized in patients hospitalized for medical illnesses. Patients with New York Heart Association class III or IV heart failure or severe respiratory disease are at increased risk for DVT, as are patients confined to bed with sepsis, stroke, leg weakness, cancer, acute rheumatologic disorders or active inflammatory bowel disease.


Related Articles

  • Central venous device-related thrombosis as imaged with MDCT in oncologic patients: prevalence and findings. Catalano, Orlando; de Lutio di Castelguidone, Elisabetta; Sandomenico, Claudia; Petrillo, Mario; Aprea, Pasquale; Granata, Vincenza; D'Errico, Adolfo Gallipoli // Acta Radiologica;Mar2011, Vol. 52 Issue 2, p148 

    Background: Venous thrombosis is a common occurrence in cancer patients, developing spontaneously or in combination with indwelling central venous devices (CVD). Purpose: To analyze the multidetector CT (MDCT) prevalence, appearance, and significance of catheterrelated thoracic venous thrombosis...

  • HEALTHBEAT. DeFrank, Jordan // New Orleans Magazine;Jun2010, Vol. 44 Issue 9, p43 

    The article offers updates related to health industry in the U.S. and Great Britain including the launch of St. Charles Fund at the Greater New Orleans Foundation by two local breast surgeons Doctor Frank DellaCroce and Doctor Scott Sullivan, the encouragement for women with potential cancer...

  • Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort Study. Eischer, Lisbeth; Tscholl, Verena; Heinze, Georg; Traby, Ludwig; Kyrle, Paul A.; Eichinger, Sabine // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    Background: Venous thromboembolism (VTE) is a multicausal disease which recurs. Hematocrit is associated with a thrombotic risk. We aimed to investigate if hematocrit is associated with the recurrence risk. Methods: Patients with a first VTE were followed after anticoagulation. Patients with VTE...

  • Cardio-oncology: A new focus for cardiovascular medicine. Hundley, W. Gregory // Hem/Onc Today;8/10/2011, Vol. 12 Issue 15, p20 

    The author reflects on the increased incidence of premature cardiovascular (CV) events in populations of cancer survivors in the U.S. as advances in treatment have reduced cancer-related mortality.

  • The relationship between venous thrombosis and subsequent arterial cardiovascular disease: causal or mediated by common etiologic factors? Roach, R.; Lijfering, W.; Flinterman, L.; Rosendaal, F.; Cannegieter, S. // International Journal of Students' Research;Sep2011, Vol. 1 Issue 3, p95 

    Introduction Previous researches have shown that patients with venous thrombosis are at an increased risk of a subsequent arterial cardiovascular event. The aim of this study was to investigate whether this was the case for all types of arterial disease and whether the risk increase was caused...

  • Antithrombogenic and antiplatelet activity of optho-isobornyl phenol derivative. M. Plotnikov; V. Smolyakova; I. Ivanov; A. Kuchin; I. Chukicheva; E. Krasnov // Bulletin of Experimental Biology & Medicine;Mar2008, Vol. 145 Issue 3, p328 

    Abstract  We studied antithrombogenic and antiplatelet properties of 4-methyl-2,6-diisobornyl phenol, a new promising compound belonging to ortho-isobornyl phenol derivatives, under conditions of intravascular thrombosis and acute cerebral ischemia. It was found that...

  • Identifying the direct effects of ammonia on the brain. Cristina Bosoi; Christopher Rose // Metabolic Brain Disease;Mar2009, Vol. 24 Issue 1, p95 

    Abstract  Elevated concentrations of ammonia in the brain as a result of hyperammonemia leads to cerebral dysfunction involving a spectrum of neuropsychiatric and neurological symptoms (impaired memory, shortened attention span, sleep-wake inversions, brain edema, intracranial...

  • Cardio-, Cerebrovascular Risks?  // Guide;Jul2003, Vol. 23 Issue 7, p54 

    Reports on the findings of a study on the relationship between the risk of cardiovascular and cerebrovascular diseases and the use of antiretroviral therapy. Number of admissions for or death from cardiovascular or cerebrovascular disease; Rates and hazards of cardiovascular and cerebrovascular...

  • A dietary approch to lipid lowering. Baic, Sue // Practice Nurse;6/8/2007, Vol. 33 Issue 11, p34 

    The article focuses on the use of diet to help reduce lipid levels. Hyperlipidaemia is a major risk factor for cardiovascular disease, such as ischaemic stroke. Dietary modification is the cornerstone of lifestyle strategies that aim to reduce lipid levels. However, the maximum reduction in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics